ATAI Life Sciences Investor
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Technology:
Mental Health Telecare
Industry:
Biotechnology, Health Care, Life Science, Therapeutics
Headquarters:
Munich, Bayern, Germany
Founded Date:
2018-01-01
Employees Number:
101-250
Funding Status:
IPO
Investor Type:
Corporate Venture Capital
Investment Stage:
Early Stage Venture, Late Stage Venture, Private Equity, Seed
Number Of Exits:
2
Acquisitions Number:
Made Acquisitions
Investors Number:
38
Total Funding:
522100000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-08-15
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership